1. Home
  2. ENTA vs EHTH Comparison

ENTA vs EHTH Comparison

Compare ENTA & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • EHTH
  • Stock Information
  • Founded
  • ENTA 1995
  • EHTH 1997
  • Country
  • ENTA United States
  • EHTH United States
  • Employees
  • ENTA N/A
  • EHTH N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • EHTH Specialty Insurers
  • Sector
  • ENTA Health Care
  • EHTH Finance
  • Exchange
  • ENTA Nasdaq
  • EHTH Nasdaq
  • Market Cap
  • ENTA 154.0M
  • EHTH 176.1M
  • IPO Year
  • ENTA 2013
  • EHTH 2006
  • Fundamental
  • Price
  • ENTA $5.10
  • EHTH $5.92
  • Analyst Decision
  • ENTA Buy
  • EHTH Buy
  • Analyst Count
  • ENTA 4
  • EHTH 4
  • Target Price
  • ENTA $17.25
  • EHTH $6.38
  • AVG Volume (30 Days)
  • ENTA 266.6K
  • EHTH 188.3K
  • Earning Date
  • ENTA 05-05-2025
  • EHTH 05-06-2025
  • Dividend Yield
  • ENTA N/A
  • EHTH N/A
  • EPS Growth
  • ENTA N/A
  • EHTH N/A
  • EPS
  • ENTA N/A
  • EHTH N/A
  • Revenue
  • ENTA $66,590,999.00
  • EHTH $532,409,999.00
  • Revenue This Year
  • ENTA N/A
  • EHTH $1.38
  • Revenue Next Year
  • ENTA N/A
  • EHTH $8.81
  • P/E Ratio
  • ENTA N/A
  • EHTH N/A
  • Revenue Growth
  • ENTA N/A
  • EHTH 17.56
  • 52 Week Low
  • ENTA $4.09
  • EHTH $3.58
  • 52 Week High
  • ENTA $17.24
  • EHTH $11.36
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 43.45
  • EHTH 34.05
  • Support Level
  • ENTA $4.55
  • EHTH $5.69
  • Resistance Level
  • ENTA $5.29
  • EHTH $6.24
  • Average True Range (ATR)
  • ENTA 0.47
  • EHTH 0.41
  • MACD
  • ENTA 0.06
  • EHTH 0.06
  • Stochastic Oscillator
  • ENTA 63.96
  • EHTH 40.41

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

Share on Social Networks: